|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500114206 |
|
最近更新日期: Date of Last Refreshed on: |
2025-12-09 10:03:45 |
|
注册时间: Date of Registration: |
2025-12-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
中国眼科门诊干眼伴视疲劳流行病学特征研究 |
|
Public title: |
Epidemiological Characteristics of Dry Eye with Visual Fatigue in Ophthalmology Outpatient Clinics in China |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
中国眼科门诊干眼伴视疲劳流行病学特征研究 |
|
Scientific title: |
Epidemiological Characteristics of Dry Eye with Visual Fatigue in Ophthalmology Outpatient Clinics in China |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
邓奇 |
研究负责人: |
刘祖国 |
|
Applicant: |
Deng Qi |
Study leader: |
Liu Zuguo |
|
申请注册联系人电话: Applicant telephone: |
+86 153 2002 1270 |
研究负责人电话:
Study leader's |
+86 189 5928 9999 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
15320021270@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zuguoliu@xmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国广东省深圳市南山区大新路创新大厦B座6楼康哲公司 |
研究负责人通讯地址: |
中国福建省厦门市思明区厦禾路336号厦门眼科中心大楼 |
|
Applicant address: |
Kangzhe Company, 6th Floor, Tower B, Innovation Building, Daxin Road, Nanshan District, Shenzhen City, Guangdong Province, China |
Study leader's address: |
Xiamen Eye Center, Xiamen University Affiliated, No. 336 Xiahe Road, Siming District, Xiamen, Fujian, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
海南康哲维盛科技有限公司 |
||
|
Applicant's institution: |
Hainan Kangzheweisheng Technology Co., Ltd |
||
|
研究负责人所在单位: |
厦门大学附属厦门眼科中心 |
||
|
Affiliation of the Leader: |
Xiamen Eye Center of Xiamen University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2025-018-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
厦门大学附属厦门眼科中心临床试验伦理委员会 |
||
|
Name of the ethic committee: |
Clinical Trial Ethics Committee of Xiamen Eye Center Affiliated with Xiamen University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-11-19 00:00:00 | ||
|
伦理委员会联系人: |
林琼凌 |
||
|
Contact Name of the ethic committee: |
Lin Qiongling |
||
|
伦理委员会联系地址: |
中国福建省厦门市思明区厦禾路336号 |
||
|
Contact Address of the ethic committee: |
No. 336, Xiahe Road, Siming District, Xiamen City, Fujian Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 592 236 7683 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
厦门大学附属厦门眼科中心 |
||||||||||||||||||||||
|
Primary sponsor: |
Xiamen Eye Center of Xiamen University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国福建省厦门市思明区厦禾路336号厦门眼科中心大楼 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Xiamen Eye Center, Xiamen University Affiliated, No. 336 Xiahe Road, Siming District, Xiamen, Fujian, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
海南康哲维盛科技有限公司 |
||||||||||||||||||||||
|
Source(s) of funding: |
Hainan Kangzheweisheng Technology Co., Ltd |
||||||||||||||||||||||
|
研究疾病: |
干眼、视疲劳 |
||||||||||||||||||||||
|
Target disease: |
Dry eye?;asthenopia?? |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
本方案将从分析中国眼科门诊人群中干眼症伴视疲劳的流行病学特征,探讨不同人群、不同环境下的患病率和临床表现。通过对不同群体的筛查,评估干眼症和视疲劳在城乡、性别、年龄、职业等不同类别中的患病率,找出高危人群。同时,还需关注疾病的分布特征,例如是否存在地区差异、年龄段差异以及与其他疾病的相关性。流行病学研究不仅能为干眼症和视疲劳的防治提供重要依据,还能帮助识别哪些群体最易患病,从而为精准干预提供理论基础。 其次分析干眼症和视疲劳的危险因素,并建立相应的风险模型。通过问卷调查、临床检查和长期随访,识别出与干眼症和视疲劳密切相关的因素,如生活习惯(如用眼时间、用眼姿势)、环境因素(如空气湿度、污染)、健康状况(如糖尿病、高血压等慢性病)以及心理状态(如压力、焦虑)。在此基础上,评估不同因素对干眼症和视疲劳的影响程度,并分析它们的相互作用,为疾病预防和干预提供科学依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
This protocol aims to investigate the epidemiological characteristics of dry eye disease (DED) with concomitant visual fatigue (asthenopia) in patients attending ophthalmic clinics across China, examining the prevalence and clinical manifestations across diverse populations and environmental contexts. Through systematic screening of different demographic groups, the study will assess the prevalence rates of DED and visual fatigue stratified by categories such as urban/rural residence, gender, age, and occupation to identify high-risk populations. Furthermore, it will focus on delineating the distribution patterns of these conditions, exploring potential regional disparities, variations across age strata, and associations with other systemic diseases. Epidemiological research of this scope not only provides critical evidence for the prevention and management of DED and visual fatigue but also aids in identifying populations most vulnerable to these conditions, thereby establishing a theoretical foundation for targeted interventions. Subsequently, the study will analyze the risk factors associated with DED and visual fatigue and develop corresponding risk prediction models. By employing structured questionnaires, comprehensive clinical examinations, and longitudinal follow-up, it seeks to identify factors closely linked to the development and progression of these conditions. These factors include lifestyle habits (e.g., duration and ergonomics of near work), environmental exposures (e.g., air humidity, pollution levels), underlying health status (e.g., chronic conditions such as diabetes and hypertension), and psychological factors (e.g., stress, anxiety). Building on this foundation, the study will evaluate the relative contribution and potential interactions of these diverse factors on DED and visual fatigue, thereby providing a scientific basis for disease prevention and the formulation of evidence-based intervention strategies. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
经标准化干眼症诊断流程确诊的干眼症患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
A patient diagnosed with dry eye syndrome following a standardized diagnostic protocol. |
||||||||||||||||||||||
|
排除标准: |
(1)既往有眼部或者眼周恶性肿瘤病史。 (2)患有继发于瘢痕(如辐射、碱烧伤、Stevens-Johnson综合征、瘢痕性类天疱疮)或结膜杯状细胞破坏(如维生素A缺乏)等而形成的干眼。 (3)眼睛或眼睑存在活动期的酒糟鼻性眼部病变、眼周痤疮或翼状胬肉。 (4)眼睑解剖学异常(如眼睑闭合不全、睑内翻或睑外翻)或眨眼异常。 (5)裂隙灯和/或眼底检查发现,且经研究者判定有临床意义的异常(包括但不限于、感染性角膜炎、倒睫、青光眼、葡萄膜炎等)。 (6)调查前180天内,进行过内眼手术或眼部激光手术以及其他任何种类影响睑板腺的手术或计划在随访期间进行以上手术或治疗。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. History of ocular or periorbital malignancy. 2. Secondary dry eye due to scarring (e.g., radiation, alkali burn, Stevens-Johnson syndrome, cicatricial pemphigoid) or goblet cell destruction (e.g., vitamin A deficiency). 3. Active ocular or periorbital manifestations of rosacea, blepharitis, or pterygium. 4. Anatomical eyelid abnormalities (e.g., lid closure insufficiency, entropion, ectropion) or abnormal blinking. 5. Ocular findings identified via slit lamp and/or fundus examination, with clinical significance as determined by the investigator (e.g., infectious keratitis, trichiasis, glaucoma, uveitis). 6. History of intraocular surgery, laser eye surgery, or any procedure affecting the meibomian glands within 180 days prior to baseline, or planned such procedures during follow-up. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-11-19 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-12-31 00:00:00 至 To 2026-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |